Loading...
OTC Markets
Totals
Securities
12,256
Dollar Vol
$49.1M
Share Vol
12.7M
Trades
1,146

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

ATTBF
Abattis Bioceuticals Corp.

Ordinary Shares
Filings and Disclosure
SEC Filings
Form Type
Form Type
Received
Received
Period End Date
Period End Date
Report
Report
RW12/09/2016PDFRTFHTML
F-104/28/2015PDFRTFHTMLXLS
D04/14/2014PDFRTFHTML
D04/03/2014PDFRTFHTML
D03/21/2012PDFRTFHTML
D/A04/06/2011PDFRTFHTML
D03/17/2011PDFRTFHTML
More
Displaying 7 of 7 Filings
Insider Disclosure
OTC Disclosure & News

No insider disclosure available for ATTBF.

SEC Transactions Last 6 Months
Buy / Sell
Buys
0
Sells
0
Total
0
Shares
Bought
0
Sold
0
Gross
0
Net
0
SEC Transactions Last 2 Years

No SEC transactions available for ATTBF.

Expert Market Icon
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
Expert Market
OTC Markets Group is unable to confirm this company is providing public disclosure to a regulator, an exchange, or OTC Markets Group.
Daily Advancers
    Subscribe to Our Newsletter
    Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.